樂
樂觀
樂觀 · 25%OSCR
$20.09
情境價格
$31.400
+0.301 (+0.96%)收盤時
Loading chart…
- 最高
- 31.760
- 開盤
- 30.900
- 成交量加權均價
- 31.34
- 成交量
- 2.84M
- 市值
- 4.19B
- 最低
- 30.850
- 成交金額
- 88.88M
- 企業價值/稅息折舊攤銷前利潤（TTM）
- 3.52
Oscar Health, Inc. is a healthcare technology company built around a full-stack technology platform. The Company serves individuals, families, and employees through the Patient Protection and Affordable Care Act (ACA). It also offers health technology solutions that power the healthcare industry through +Oscar. It also wholly owns three businesses operating in the individual market: Lucie, Inc., a technology enrollment platform for consumers, employers and brokers; Trove Group Inc., an insurance agency that sells individual medical and supplemental health products, and HealthInsurance.org, LLC, a lead generation website providing educational content to help consumers navigate health insurance as well as the ACA and Medicare marketplaces.
AI 分析 of Oscar Health Inc (OSCR)
買進Oscar Health Inc is a good buy right now, with a current price of $30.99 and a strong year-to-date change of +107.01%. The company has shown significant revenue growth, with Q1 2026 revenue reaching $4.65 billion and a net income of $678 million. The forward P/E ratio is extremely high at 588.24, indicating potential future growth expectations, but this also presents a risk if growth does not materialize as anticipated. The RSI is currently at 30.777, suggesting that the stock is oversold, which could indicate a buying opportunity.
估值指標
Oscar Health Inc（OSCR）目前預期本益比為 588.24，5 年平均預期本益比為 127.22。
Alphio AI 對 OSCR 的價格情境
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重（25 / 50 / 25），不構成保證。
持有 OSCR 的大戶
事件時間軸
資訊
8.510-20NewsfilterOscar Insurance Unveils 2027 Health Insurance Lineup
- 9.510-12Newsfilter
Oscar Health to Release Q3 2026 Financial Results on November 5
2.009-30FoolInvestors Overlook Healthcare Sector Amid AI Focus
5.009-25FoolFour Overlooked Stocks with Doubling Potential
- 8.509-19Newsfilter
Oscar Health Share Distribution of 6.3 Million Shares by Thrive Capital
OSCR 常見問題 —— 由 Alphio AI 解答
Oscar Health, Inc. is a healthcare technology company built around a full-stack technology platform. The Company serves individuals, families, and employees through the Patient Protection and Affordable Care Act (ACA). It also offers health technology solutions that power the healthcare industry through +Oscar. It also wholly owns three businesses operating in the individual market: Lucie, Inc., a technology enrollment platform for consumers, employers and brokers; Trove Group Inc., an insurance agency that sells individual medical and supplemental health products, and HealthInsurance.org, LLC, a lead generation website providing educational content to help consumers navigate health insurance as well as the ACA and Medicare marketplaces. It operates in the Financials sector (HOSPITAL & MEDICAL SERVICE PLANS industry).
Oscar Health Inc is a good buy right now, with a current price of $30.99 and a strong year-to-date change of +107.01%. The company has shown significant revenue growth, with Q1 2026 revenue reaching $4.65 billion and a net income of $678 million. The forward P/E ratio is extremely high at 588.24, indicating potential future growth expectations, but this also presents a risk if growth does not materialize as anticipated. The RSI is currently at 30.777, suggesting that the stock is oversold, which could indicate a buying opportunity.
社群
更多 ↗
$OSCR It has reached the monthly pullback zone. Breaking through this resistance level could trigger a new upward move.
展開
$OSCR is forming a dangerous wedge. Price could still push higher from here, but the pattern is becoming increasingly worth watching. This is definitely something I'm keeping a close eye on. 👀
展開
$oscr is finishing up a 5 year IPO base. In 2021 they did $1.84B in revenue. This year they will do 10X. You missed nothing. This is the beginning
展開
$OSCR CMS has cracked down on unauthorized enrollments after tracking a surge in consumer complaints, analyzing statistically implausible application rates submitted by specific brokers, and reviewing accounts missing critical identifying information like Social Security numbers. They have canceled approximately 315,000 unauthorized enrollments covering more than 760,000 individuals, which is expected to result in a return of roughly $2.2B in taxpayer-funded subsidies. Oscar Health accounted for >250,000 of these enrollments!
展開本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。